Get the Stockscreener App
7.85
2.12%
-0.17
Biodesix Inc stock is traded at $7.85, with a volume of 30,759.
It is down -2.12% in the last 24 hours and down -1.26% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$8.02
Open:
$8
24h Volume:
30,759
Relative Volume:
0.20
Market Cap:
$62.45M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-12.08
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
+2.28%
1M Performance:
-1.26%
6M Performance:
+30.88%
1Y Performance:
-69.57%
1-Day Range:
$7.79
$8.19
1-Week Range:
$7.2375
$8.38
52-Week Range:
$3.436
$32.20
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
7.85 | 63.80M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jul-26-24 | Initiated | Craig Hallum | Buy |
| May-13-24 | Initiated | TD Cowen | Buy |
| May-03-24 | Initiated | Lake Street | Buy |
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays - MSN
Is Biodesix Stock Built to Withstand More Downside? - Trefis
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Loss Report: Can Biodesix Inc stock continue upward trendTake Profit & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
Would You Still Hold Biodesix Stock If It Fell 30%? - Trefis
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 325.67%: Here's is How to Trade - Eastern Progress
BDSX FinancialsIncome Statement - Quiver Quantitative
Biodesix, Inc. to Present Clinical Data for Nodify Lung® Tests and New ESR1 Assay at Major Oncology Conferences - Quiver Quantitative
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings - GlobeNewswire
Will Biodesix Inc. stock deliver strong dividend growth2025 Major Catalysts & Safe Capital Growth Plans - Newser
Will Biodesix Inc. stock gain from strong economy2025 Macro Impact & Daily Volume Surge Signals - Newser
Biodesix, Inc.'s (NASDAQ:BDSX) Shares Leap 27% Yet They're Still Not Telling The Full Story - simplywall.st
Macro Review: Is Biodesix Inc. stock affected by interest rate hikesPortfolio Return Summary & Daily Profit Maximizing Tips - BỘ NỘI VỤ
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Can Biodesix Inc. stock continue upward trendWeekly Trade Recap & Free Risk Controlled Daily Trade Plans - moha.gov.vn
Biodesix Reports Strong Q3 2025 Revenue Growth - MSN
Is Biodesix Inc. stock attractive for hedge fundsMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
What drives Biodesix Inc stock priceEconomic Indicators Overview & Rapid Wealth Building Tips - earlytimes.in
Can OBSC Perfection Limited Beat EPS Estimates in the Next QuarterTechnical Breakout Signals & Free High Impact Stock Picks - earlytimes.in
Is Biodesix Inc. a candidate for recovery playJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Advanced analytics toolkit walkthrough for Biodesix Inc.2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Top chart patterns to watch in Biodesix Inc.Quarterly Market Summary & Reliable Breakout Forecasts - newser.com
Is Biodesix Inc. stock a bargain at current levelsWeekly Market Summary & Stock Market Timing Techniques - newser.com
Biodesix Inc. recovery potential after sell offJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Is Biodesix Inc. stock a good choice for value investorsPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Is Biodesix Inc. stock a defensive play in 2025Portfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Can Biodesix Inc. stock rebound after recent weakness2025 Trading Recap & Reliable Breakout Forecasts - newser.com
What momentum indicators show for Biodesix Inc. stockMarket Rally & Growth Oriented Trade Recommendations - newser.com
CEO Hutton Acquires 422 Of Biodesix Inc [BDSX] - TradingView
How risky is Biodesix Inc. stock now2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):